-transparent.png){kind=logo}
The effects of the antiviral agent, inosiplex, were assessed in four patients with Paget's disease of bone. Treatment for 6 months did not suppress disease activity as judged by serum alkaline phosphatase and hydroxyprolinuria, and viral inclusions persisted in the one patient from whom a bone biopsy was taken. These results contrasted markedly with the suppressive effects of diphosphonate treatment in these same patients.
Related Publications
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
May 1974,
Lancet (London, England),
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
January 1987,
Revue medicale de Bruxelles,
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
April 1981,
Schweizerische medizinische Wochenschrift,
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
January 1978,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
August 1973,
Lancet (London, England),
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
October 1980,
Arthritis and rheumatism,
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
February 1980,
Lancet (London, England),
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
April 1979,
Arthritis and rheumatism,
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
May 1971,
Lancet (London, England),
J A Kanis, and
C J Preston, and
D J Beard, and
M Beneton, and
S Harris, and
R G Russell
January 1981,
Metabolic bone disease & related research,
